Towards Healthcare
IVD Diagnostic Molecule Raw Enzymes Market to Rise at 7.13% CAGR till 2034

IVD Diagnostic Molecule Raw Enzymes Market Future Expansion

The IVD diagnostic molecule raw enzymes market is valued at USD 2.39 billion in 2024, projected to reach USD 4.73 billion by 2034 at a 7.13% CAGR. It includes segmentation by enzyme type, application, and technology, with leading regions like North America (45.9%) and Asia Pacific. The study covers trade data, supply chain, key players like QIAGEN, Bio-Rad, and Merck KGaA, and full value chain insights.

Content

  • Last Updated: 24 October 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

The IVD diagnostic molecule raw enzymes market in 2025 is valued at USD 2.56 billion and is projected to climb to USD 4.73 billion by 2034, with a CAGR of 7.13% over the forecast period.

North America is currently leading the IVD diagnostic molecule raw enzymes market share by 45.9% due to the presence of a well-developed healthcare infrastructure.

The IVD diagnostic molecule raw enzymes market includes five segments such as by enzyme type, by application, by technology, by end-user, and by region.

Some key players include New England Biolabs, QIAGEN, Bio-Rad Laboratories, and Takara Bio.

Growth in the oncology genetic testing is the factor that drives the market growth.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.
Any Questions